University Hospital of Bern-ko ikertzaileekin lankidetzan egindako argitalpenak (17)

2024

  1. Embolization of percutaneous left atrial appendage closure devices: timing, management and clinical outcomes

    Cardiovascular Revascularization Medicine

  2. Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study

    JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387

2023

  1. Symptomatic vs. non-symptomatic device-related thrombus after LAAC: a sub-analysis from the multicenter EUROC-DRT registry

    Clinical Research in Cardiology, Vol. 112, Núm. 12, pp. 1790-1799

2022

  1. Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry

    Clinical Research in Cardiology, Vol. 111, Núm. 11, pp. 1276-1285

  2. Early Clinical Experience With the TRICENTO Bicaval Valved Stent for Treatment of Symptomatic Severe Tricuspid Regurgitation: A Multicenter Registry

    Circulation. Cardiovascular interventions, Vol. 15, Núm. 3, pp. e011302

2021

  1. Device-Related Thrombus After Left Atrial Appendage Closure: Data on Thrombus Characteristics, Treatment Strategies, and Clinical Outcomes From the EUROC-DRT-Registry

    Circulation: Cardiovascular Interventions, Vol. 14, Núm. 5, pp. E010195

  2. ST-Segment Elevation Myocardial Infarction Following Transcatheter Aortic Valve Replacement

    Journal of the American College of Cardiology, Vol. 77, Núm. 17, pp. 2187-2199

2020

  1. Left atrial appendage occlusion for stroke despite oral anticoagulation (resistant stroke). Results from the Amplatzer Cardiac Plug registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 28-34

2017

  1. Incidence and Clinical Impact of Device-Associated Thrombus and Peri-Device Leak Following Left Atrial Appendage Closure With the Amplatzer Cardiac Plug

    JACC: Cardiovascular Interventions, Vol. 10, Núm. 4, pp. 391-399

  2. Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation and Previous Major Gastrointestinal Bleeding (from the Amplatzer Cardiac Plug Multicenter Registry)

    American Journal of Cardiology, Vol. 120, Núm. 3, pp. 414-420

  3. Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry

    International Journal of Cardiology, Vol. 236, pp. 232-236

2016

  1. Characterization of Cerebrovascular Events After Left Atrial Appendage Occlusion

    American Journal of Cardiology, Vol. 118, Núm. 12, pp. 1836-1841

  2. Comparison of Efficacy and Safety of Left Atrial Appendage Occlusion in Patients Aged <75 to ≥75 Years

    American Journal of Cardiology, Vol. 117, Núm. 1, pp. 84-90

  3. Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation

    International Journal of Cardiology, Vol. 207, pp. 335-340

  4. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: Multicentre experience with the AMPLATZER Cardiac Plug

    EuroIntervention, Vol. 11, Núm. 10, pp. 1170-1179

  5. Left atrial appendage occlusion with the AMPLATZER Amulet device: An expert consensus step-by-step approach

    EuroIntervention, Vol. 11, Núm. 13, pp. 1512-1521

2008

  1. Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: A 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-Delft)

    EuroIntervention, Vol. 4, Núm. 1, pp. 77-83